MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses

Eur J Immunol. 1984 Mar;14(3):260-7. doi: 10.1002/eji.1830140311.


A mouse monoclonal antibody, designated MRC OX-19, has been prepared that binds to virtually all rat thymocytes, T lymphocytes and a maximum of 2% B lymphocytes. Immunoperoxidase studies on tissue sections showed no reactivity with nonlymphoid cells in intestine, thymus, spleen and lymph node. The antigen recognized by MRC OX-19 antibody was identified by metabolic and cell surface labeling of thymocytes followed by immunoprecipitation and sodium dodecyl sulfate gel electrophoresis. It is a surface glycoprotein of Mr = 69 000. When included in in vitro assays for T cell functions, MRC OX-19 increased proliferation stimulated by allogeneic spleen cells or the lectins phytohemagglutinin and concanavalin A. The antibody itself was not mitogenic and its stimulatory effect could be correlated with an increase in interleukin 2 production. Taken together the data suggest that MRC OX-19 could be the equivalent of mouse Ly-1 antigen and human T1 antigen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / physiology
  • Antigens, Surface / immunology
  • Binding Sites, Antibody*
  • Binding, Competitive
  • Interleukin-2 / biosynthesis
  • Lymph Nodes / metabolism
  • Lymphocyte Activation*
  • Lymphocyte Culture Test, Mixed
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Rats
  • Rats, Inbred Strains
  • Rats, Mutant Strains
  • Spleen / metabolism
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes, Cytotoxic / immunology
  • Thoracic Duct / metabolism


  • Antibodies, Monoclonal
  • Antigens, Surface
  • Interleukin-2